Lupin receives USFDA approval for Atorvastatin Calcium tablets

Lupin has received USFDA approval to market its generic Atorvastatin Calcium tablets, used for lowering cholesterol, in the American market. The product will be made available in strengths of 10 mg, 20 mg, 40 mg, and 80 mg. The product is a generic version of Pfizer Inc’s Lipitor tablets in the same strengths. The tablets are prescribed to lower cholesterol in blood for adults and children over 10 years of age. According to market estimates, Atorvastatin Calcium tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg had annual sales of around USD 696 million in the US.

Company Profile : Lupin Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.